{
    "clinical_study": {
        "@rank": "31951", 
        "acronym": "PRESERVE-EF", 
        "arm_group": {
            "arm_group_label": "Post-MI patients", 
            "description": "Asymptomatic post-MI patients late after MI or 40 days after STEMI-NSTEMI with preserved ejection fraction and absence of active ischemia Programmed ventricular stimulation will be performed in high-risk patients based on non-invasive evaluation.\nICD  implantation will be performed in patients with induced VT in programmed ventricular stimulation"
        }, 
        "brief_summary": {
            "textblock": "The purpose of the study is to assess the prevalence and the prognostic value of\n      non-invasive indexes and programmed ventricular stimulation for sudden cardiac death in\n      post-MI patients with LVEF >40%."
        }, 
        "brief_title": "Risk Stratification in Patients With Preserved Ejection Fraction", 
        "completion_date": {
            "#text": "April 2019", 
            "@type": "Anticipated"
        }, 
        "condition": "Myocardial Infarction", 
        "condition_browse": {
            "mesh_term": [
                "Infarction", 
                "Myocardial Infarction", 
                "Death, Sudden, Cardiac", 
                "Death"
            ]
        }, 
        "detailed_description": {
            "textblock": "1000 asymptomatic post-MI patients>40%, at least 40 days till 3 years post-MI,\n      revascularized or without needing further revascularization (in any case without any\n      evidence of ischemia) will be enrolled.\n\n      The patients will be divided into two categories:\n\n        1. Asymptomatic patients with revascularized STEMI (remaining stenoses in non culprit\n           vessels <70%) at 40 days post-MI (when LVEF>40% will be re-assessed)\n\n        2. Asymptomatic patients late (till 3 years) after MI (initially STEMI-NSTEMI at discharge\n           Q-non Q) with LVEF>40% right after a negative stress test or right after a negative for\n           stenoses control coronary catheterization All patients will undergo non-invasive\n           evaluation (ECG, Holter monitoring and 45-min high resolution recording). In case they\n           fulfill at least one out of seven pre-specified criteria they will undergo programmed\n           ventricular stimulation and ICD implantation (if inducible) All patients will be\n           followed-up for 3 years for sudden cardiac death and its surrogate (appropriate ICD\n           activation)"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Asymptomatic patients with revascularized STEMI (remaining stenoses in non culprit\n             vessels <70%) at 40 days post-MI (when LVEF>40% will be re-assessed)\n\n          -  Asymptomatic patients late after MI (initially STEMI-NSTEMI at discharge Q-non Q)\n             with LVEF>40% right after a negative stress test or right after a negative for\n             stenoses control coronary catheterization\n\n        Exclusion Criteria:\n\n          -  Episodes of sustained VT or aborted SCD 48 hours after the acute MI phase.\n\n          -  Episodes of syncope within the last 6 months\n\n          -  Cancer, liver failure (cirrhosis), end-stage renal disease\n\n          -  Use of anti-arrhythmic drugs other than b-blockers"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "1000 asymptomatic post-MI patients>40%, at least 40 days post-MI, revascularized or\n        without needing further revascularization (in any case without any evidence of ischemia)\n\n        The patients will be divided into two categories:\n\n          1. Asymptomatic patients with revascularized STEMI (remaining stenoses in non culprit\n             vessels <70%) at 40 days post-MI (when LVEF>40% will be re-assessed)\n\n          2. Asymptomatic patients late after MI (initially STEMI-NSTEMI at discharge Q-non Q)\n             with LVEF>40% right after a negative stress test or right after a negative for\n             stenoses control coronary catheterization"
            }
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 24, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02124018", 
            "org_study_id": "UOA-PRESERVE1"
        }, 
        "intervention": [
            {
                "arm_group_label": "Post-MI patients", 
                "description": "Programmed ventricular stimulation in high-risk patients based on non-invasive evaluation", 
                "intervention_name": "Programmed ventricular stimulation", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Post-MI patients", 
                "description": "ICD implantation in patients with induced VT in programmed ventricular stimulation", 
                "intervention_name": "ICD implantation", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Myocardial infarction", 
            "Risk stratification", 
            "Sudden cardiac death", 
            "Preserved ejection fraction", 
            "Programmed ventricular stimulation"
        ], 
        "lastchanged_date": "April 25, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Athens", 
                    "country": "Greece", 
                    "zip": "11527"
                }, 
                "name": "First Cardiology Clinic, Hippokration Hospital"
            }
        }, 
        "location_countries": {
            "country": "Greece"
        }, 
        "number_of_groups": "1", 
        "official_title": "Post Myocardial Infarction Risk Stratification for Sudden Cardiac Death in Patients With Preserved Ejection Fraction: PRESERVE-EF", 
        "other_outcome": {
            "description": "Correlation of  non-invasive indexes (SAECG, Holter monitoring) with VT induction in PVS", 
            "measure": "Predictors of VT inducibility", 
            "safety_issue": "No", 
            "time_frame": "Baseline evaluation"
        }, 
        "overall_official": {
            "affiliation": "University of Athens, Hippokration Hospital", 
            "last_name": "Konstantinos Gatzoulis, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Greece: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Prevalence and prognostic value (positive and negative) of non-invasive and invasive indexes for SCD and appropriate ICD activation", 
            "measure": "Sudden cardiac death, sustained VT, appropriate ICD activation", 
            "safety_issue": "No", 
            "time_frame": "From enrollment till 3 years of follow-up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02124018"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Athens", 
            "investigator_full_name": "Kostantinos A. Gatzoulis", 
            "investigator_title": "Assoc. Professor of Cardiology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Repeat non-invasive indexes in fresh STEMI (first control in 40 days post-MI) 1 year later", 
            "measure": "Non-invasive indexes variability", 
            "safety_issue": "No", 
            "time_frame": "1 year after enrollment"
        }, 
        "source": "University of Athens", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Medtronic", 
                    "agency_class": "Industry"
                }, 
                {
                    "agency": "General Electric", 
                    "agency_class": "Industry"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of Athens", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "3 Years", 
        "verification_date": "April 2014"
    }
}